250 related articles for article (PubMed ID: 28785376)
1. Neuroprotection of Catalpol for Experimental Acute Focal Ischemic Stroke: Preclinical Evidence and Possible Mechanisms of Antioxidation, Anti-Inflammation, and Antiapoptosis.
Zheng XW; Yang WT; Chen S; Xu QQ; Shan CS; Zheng GQ; Ruan JC
Oxid Med Cell Longev; 2017; 2017():5058609. PubMed ID: 28785376
[TBL] [Abstract][Full Text] [Related]
2. Lyophilized Powder of Catalpol and Puerarin Protected Cerebral Vessels from Ischemia by Its Anti-apoptosis on Endothelial Cells.
Liu Y; Tang Q; Shao S; Chen Y; Chen W; Xu X
Int J Biol Sci; 2017; 13(3):327-338. PubMed ID: 28367097
[TBL] [Abstract][Full Text] [Related]
3. Multiple Biological Effects of an Iridoid Glucoside, Catalpol and Its Underlying Molecular Mechanisms.
Bhattamisra SK; Yap KH; Rao V; Choudhury H
Biomolecules; 2019 Dec; 10(1):. PubMed ID: 31878316
[TBL] [Abstract][Full Text] [Related]
4. Astragaloside IV for Experimental Focal Cerebral Ischemia: Preclinical Evidence and Possible Mechanisms.
Wang HL; Zhou QH; Xu MB; Zhou XL; Zheng GQ
Oxid Med Cell Longev; 2017; 2017():8424326. PubMed ID: 28303172
[TBL] [Abstract][Full Text] [Related]
5. Amelioration by catalpol of atherosclerotic lesions in hypercholesterolemic rabbits.
Liu JY; Zhang DJ
Planta Med; 2015 Feb; 81(3):175-84. PubMed ID: 25671384
[TBL] [Abstract][Full Text] [Related]
6. Catalpol decreases peroxynitrite formation and consequently exerts cardioprotective effects against ischemia/reperfusion insult.
Huang C; Cui Y; Ji L; Zhang W; Li R; Ma L; Xing W; Zhou H; Chen B; Yu J; Zhang H
Pharm Biol; 2013 Apr; 51(4):463-73. PubMed ID: 23336403
[TBL] [Abstract][Full Text] [Related]
7. Catalpol: a potential therapeutic for neurodegenerative diseases.
Jiang B; Shen RF; Bi J; Tian XS; Hinchliffe T; Xia Y
Curr Med Chem; 2015; 22(10):1278-91. PubMed ID: 25620103
[TBL] [Abstract][Full Text] [Related]
8. Peptidic exenatide and herbal catalpol mediate neuroprotection via the hippocampal GLP-1 receptor/β-endorphin pathway.
Jia Y; Gong N; Li TF; Zhu B; Wang YX
Pharmacol Res; 2015 Dec; 102():276-85. PubMed ID: 26546042
[TBL] [Abstract][Full Text] [Related]
9. Bioactivities of Natural Catalpol Derivatives.
Zhang LQ; Chen KX; Li YM
Curr Med Chem; 2019; 26(33):6149-6173. PubMed ID: 31218947
[TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory effect and mechanism of catalpol in various inflammatory diseases.
Liu J; Liu S; Yu M; Li J; Xie Z; Gao B; Liu Y
Drug Dev Res; 2023 Nov; 84(7):1376-1394. PubMed ID: 37534768
[TBL] [Abstract][Full Text] [Related]
11. Catalpol provides protective effects against cerebral ischaemia/reperfusion injury in gerbils.
Liu YR; Li PW; Suo JJ; Sun Y; Zhang BA; Lu H; Zhu HC; Zhang GB
J Pharm Pharmacol; 2014 Sep; 66(9):1265-70. PubMed ID: 24720795
[TBL] [Abstract][Full Text] [Related]
12. Remote ischemic perconditioning in thrombolysed stroke patients: randomized study of activating endogenous neuroprotection - design and MRI measurements.
Hougaard KD; Hjort N; Zeidler D; Sørensen L; Nørgaard A; Thomsen RB; Jonsdottir K; Mouridsen K; Hansen TM; Cho TH; Nielsen TT; Bøtker HE; Østergaard L; Andersen G
Int J Stroke; 2013 Feb; 8(2):141-6. PubMed ID: 22463392
[TBL] [Abstract][Full Text] [Related]
13. Deciphering the neuroprotective mechanisms of Bu-yang Huan-wu decoction by an integrative neurofunctional and genomic approach in ischemic stroke mice.
Wang HW; Liou KT; Wang YH; Lu CK; Lin YL; Lee IJ; Huang ST; Tsai YH; Cheng YC; Lin HJ; Shen YC
J Ethnopharmacol; 2011 Oct; 138(1):22-33. PubMed ID: 21784143
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotection of catalpol in transient global ischemia in gerbils.
Li DQ; Duan YL; Bao YM; Liu CP; Liu Y; An LJ
Neurosci Res; 2004 Oct; 50(2):169-77. PubMed ID: 15380324
[TBL] [Abstract][Full Text] [Related]
15. MORIN MITIGATES OXIDATIVE STRESS, APOPTOSIS AND INFLAMMATION IN CEREBRAL ISCHEMIC RATS.
Chen Y; Li Y; Xu H; Li G; Ma Y; Pang YJ
Afr J Tradit Complement Altern Med; 2017; 14(2):348-355. PubMed ID: 28573251
[TBL] [Abstract][Full Text] [Related]
16. Effects of catalpol on ATPase and amino acids in gerbils with cerebral ischemia/reperfusion injury.
Liu YR; Lei RY; Wang CE; Zhang BA; Lu H; Zhu HC; Zhang GB
Neurol Sci; 2014 Aug; 35(8):1229-33. PubMed ID: 24584634
[TBL] [Abstract][Full Text] [Related]
17. Feasibility of Catalpol Intranasal Administration and Its Protective Effect on Acute Cerebral Ischemia in Rats via Anti-Oxidative and Anti-Apoptotic Mechanisms.
Wang J; Zhang Y; Zhang M; Sun S; Zhong Y; Han L; Xu Y; Wan D; Zhang J; Zhu H
Drug Des Devel Ther; 2022; 16():279-296. PubMed ID: 35115763
[TBL] [Abstract][Full Text] [Related]
18. [Borneol promotes catalpol and puerarin crossing through blood-brain barrier in focal cerebral ischemic rats].
Wu JJ; Wang HJ; Yang S; Liu Y; Xu XY
Zhongguo Zhong Yao Za Zhi; 2016 Nov; 41(21):3988-3995. PubMed ID: 28929686
[TBL] [Abstract][Full Text] [Related]
19. Valproic acid attenuates ischemia-reperfusion injury in the rat brain through inhibition of oxidative stress and inflammation.
Suda S; Katsura K; Kanamaru T; Saito M; Katayama Y
Eur J Pharmacol; 2013 May; 707(1-3):26-31. PubMed ID: 23541723
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of catalpol on lipopolysaccharide-induced acute lung injury in mice.
Fu K; Piao T; Wang M; Zhang J; Jiang J; Wang X; Liu H
Int Immunopharmacol; 2014 Dec; 23(2):400-6. PubMed ID: 25063711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
